Anticipates Reporting First Quarter Revenue of Approximately $1.3 Million, Reflecting 78% Year-Over-Year Growth, and Gross Profit Growth of Approximately 115% Year-Over-Year ...
Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results